Man Group
ETON icon

Man Group’s Eton Pharmaceutcials ETON Stock Holding History

Man Group’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,473
Closed -$177K – 2448
2025
Q4 		$177K Sell
10,473
-2,176
-17% -$38.3K ﹤0.01% 2143
2025
Q3 		$275K Sell
12,649
-11,105
-47% -$184K ﹤0.01% 2034
2025
Q2 		$338K Buy
23,754
+1,350
+6% +$21.3K ﹤0.01% 1934
2025
Q1 		$291K Buy
+22,404
New +$339K ﹤0.01% 1942

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Man Group's ETON Position: Q1 2026 in Review

Man Group sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 10,473 shares — an estimated $177K sold.

Man Group first reported a position in ETON in Q1 2025 and held it in 4 quarters. The position peaked at $338K in Q2 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Man Group reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 10,473 Eton Pharmaceutcials shares in Q1 2026, an estimated $177K.
  • Man Group first reported a position in Eton Pharmaceutcials in Q1 2025 and held it in 4 quarters.
  • Man Group's Eton Pharmaceutcials position peaked at $338K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.